Parkinson's Disease Therapeutics Conference

Attendee arrivals and networking

Mark Frasier, PhD, The Michael J. Fox Foundation

2:55-3:25PM — First Room of Your Choice 
3:35-4:05PM — Second Room of Your Choice 
4:15-4:45PM — Third Room of Your Choice

ROOM OPTIONS

Room A: Advancing Targets to Therapies

Allie Vaina, PhD, The Michael J. Fox Foundation
Gaia Skibinski, PhD, The Michael J. Fox Foundation
Fiona Ducotterd, PhD, University College London
Jonathan Behr, PhD, Advisor to the Michael J. Fox Foundation

Explore how MJFF’s Targets to Therapies resources can help industry evaluate emerging PD targets and inform decisions about which opportunities to advance

Room B: PPMI and Enabling Clinical Trials in PD

Catherine Kopil, PhD, The Michael J. Fox Foundation
Kenneth Marek, MD, Institute for Neurodegenerative Disorders
Tanya Simuni, MD, FAAN, Northwestern University Feinberg School of Medicine

Learn how PPMI and related MJFF infrastructure are generating the data, biomarkers and regulatory insights needed to design more efficient and effective PD clinical trials

Room C: Pathway Toolkits: Biofluid Measurements of Biological Pathways

Ariana Farrand, PhD, The Michael J. Fox Foundation
Christine Swanson Fischer, PhD, The Michael J. Fox Foundation
Katrina Paumier, PhD, Octave Neuroscience

Explore MJFF’s biomarker toolkits and resources for measuring key PD biological pathways, and help shape how these drug development tools can better support clinical development  

Room D: Multimodal Data and Analyses

Samantha Hutten, PhD, The Michael J. Fox Foundation
Chris Whelan, PhD, Ignition Scientific
Kendall Jensen, PhD, TGen

Learn how rapidly expanding multimodal datasets from PPMI, GP2 and other efforts can be leveraged for target discovery, patient stratification, biomarker development and trial design

Room E: Patient-Centered Strategies for Drug Development

Maggie Kuhl, The Michael J. Fox Foundation
Wes Kutler, The Michael J. Fox Foundation

Learn how incorporating patient insights earlier in therapeutic development can strengthen R&D decisions, and how MJFF can help companies engage the patient community along the way

Networking reception

Arrivals and Breakfast

Sohini Chowdhury, The Michael J. Fox Foundation

9:05-9:15AM — SESSION INTRODUCTION FROM SESSION CHAIR 
Magdalene Moran, PhD, Topo Therapeutics

9:15-10:30AM — COMPANY FAST FIRE PRESENTATIONS

9:15-9:30AM — Brain Shuttle-Enabled Delivery of a TrkB Agonist Antibody for Disease Modification in Parkinson’s Disease 
Pawel Stocki, PhD, Ossianix

9:30-9:45AM — 20S Proteasome activation for the treatment of Parkinson’s Disease 
Diogo Feleciano, PhD, Booster Therapeutics

9:45-10:00AM — Mitochondrial Program   
Richard Rutter, PhD, NRG Therapeutics

10:00-10:15AM — GBA1 Program 
Leon Murphy, PhD, Casma Therapeutics

10:15-10:30AM — HER-096: a subcutaneous CDNF-derived peptide for Parkinson’s disease—rationale and Phase 1b results 
Henri Huttunen, PhD, Herantis Pharma Plc

10:40-11:15AM — PANEL DISCUSSION

Networking break and poster viewing

11:55-12:05PM — SESSION INTRODUCTION FROM SESSION CHAIR 
Johannes Streffer, MD, Lundbeck

12:05-12:25PM — aSyn PET Tracer - State of the Field 
Jamie Eberling, PhD, The Michael J. Fox Foundation

12:25-12:45PM — Detect PD: simple blood-based testing for development and progression of neuronal alpha-synuclein disease 
Julia Carrasco Zanini Sanchez, PhD, Queen Mary University of London 
Celine Roder, Queen Mary University of London

12:45-1:05PM — Polygenic risk score as predictor of NSD progression 
Manuela Tan, PhD, Queen Mary University of London

1:05-1:25PM — Multivariate latent disease progression modeling in Neuronal a-Synuclein Disease 
Barbara Wendelberger, PhD, Berry Consultants

1:30-1:40PM — CLOSING REMARKS & AUDIENCE QUESTIONS

Lunch, networking break and poster viewing

3:00-3:15PM — SESSION INTRODUCTION FROM SESSION CHAIR 
Brian Fiske, PhD, The Michael J. Fox Foundation

3:15-4:00PM — PANEL DISCUSSION 
Moderator: Brian Fiske, PhD, The Michael J. Fox Foundation
Panelists: Patrik Brundin, PhD, Roche; Joohi Jimenez-Shahed, MD, Mt Sinai

4:05-4:15PM — CLOSING REMARKS 
Sohini Chowdhury, The Michael J. Fox Foundation

POSTER SESSION

DaT Clock 
Roger Gunn, PhD, XingImaging

Novartis PPMI Data Collaboration 
Piet Aarden, Novartis

Cognition Endpoints Roadmap 
Chris Edgar, PhD, PCOA

Is there a virtual option for the Conference? Will it be recorded?

Unfortunately, we are not livestreaming or recording the Conference. 

Can I present my research at the Conference?

We have already selected our speakers for the conference. Generally, our speakers are nominated and identified by members of MJFF's Research Leadership team who work to craft the programmatic themes for the event. For more information, please email pdtc@michaeljfox.org. 

Can I present my abstract at the Conference?

Thank you for your interest in presenting at the Conference. We do not accept abstracts for this conference. Poster presenters are by MJFF’s leadership team based on the grants that we fund. For more information, please email pdtc@michaeljfox.org.  

When will the Conference agenda be available?

The agenda will be made available in the Fall.  

How can my organization sponsor the Parkinson’s Disease Therapeutics Conference?

Thank you for your interest in sponsoring the Parkinson’s Disease Therapeutics Conference! You can view our sponsorship opportunities menu here. If you are interested in learning more, please email pdtc@michaeljfox.org.

Where is the Conference taking place?

The Parkinson’s Disease Therapeutics Conference will take place at Quorum by Convene at 1221 Avenue of Americas, New York, NY 10020.

How do I get to the Parkinson’s Disease Therapeutics Conference venue?

Please review this document to find the best route for you to travel to the venue. Upon entrance at 1221 Avenue of the Americas on 49th Street between 6th Ave and 7th Ave, please take the escalator on your right up to the second floor. There you will be greeted by the Convene Welcome Desk and directed to check-in for the Parkinson’s Disease Therapeutics Conference.

How can I find out information about hotels and their rates for this Conference?

When you register, your confirmation email will include information about the hotel block associated with the Conference. If you have questions, please contact pdtc@michaeljfox.org.  

How do I apply for a visa to travel to the United States?

Visa regulations depend on your nationality and country of origin. We suggest you contact your local Consulate for full and official instructions on the specific visa regulations and application procedure that apply to you.

Where can I get a conference invitation letter so that I can apply for a visa?

Invitation letters for visa purposes are available only to registered attendees. If you need an invitation letter, please email pdtc@michaeljfox.org.  

Is it possible to send an official invitation letter directly to my local Consulate?

Unfortunately, we are unable to send invitation letters directly to consulates. Invitation letters are prepared solely for individuals and are emailed directly to them.